Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Avalon GloboCare Corp. Common Stock (ALBT)

Biological Products, (no Disgnostic Substances)

https://www.avalon-globocare.com

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

4400 ROUTE 9, SUITE 3100
FREEHOLD, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/22/2016

Market Cap

3,455,862

Shares Outstanding

11,000,000

Weighted SO

10,999,534

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

ACNDF --.--%

ASPZ --.--%

ADPPF --.--%

AZLCZ --.--%

ABCP --.--%

AANNF --.--%

BREUF --.--%

AGTK --.--%

Beta

0.3180

Last Div

0.0000

Range

0.24-1.44

Chg

-0.1100

Avg Vol

7057029

Mkt Cap

3455862

Exch

NASDAQ

Country

US

Phone

732 780 4400

DCF Diff

0.3146

DCF

0.0144

Div Yield

0.0000

P/S

2.7124

EV Multiple

-2.5706

P/FV

0.6194

Div Yield %

0.0000

P/E

-0.2508

PEG

0.0148

Payout

0.0000

Current Ratio

0.0772

Quick Ratio

0.0772

Cash Ratio

0.0391

DSO

25.2709

DIO

0.0000

Op Cycle

25.2709

DPO

0.0000

CCC

25.2709

Gross Margin

0.1621

Op Margin

-3.7716

Pretax Margin

-11.7345

Net Margin

-11.7345

Eff Tax Rate

-0.0900

ROA

-0.7353

ROE

-1.2357

ROCE

-0.3835

NI/EBT

1.0000

EBT/EBIT

3.1113

EBIT/Rev

-3.7716

Debt Ratio

0.4139

D/E

1.3901

LT Debt/Cap

0.5168

Total Debt/Cap

0.5816

Int Coverage

-2.8032

CF/Debt

-0.6580

Equity Multi

3.3587

Rec Turnover

14.4435

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

9.2146

Asset Turnover

0.0627

OCF/Share

-0.5021

FCF/Share

-0.5023

Cash/Share

0.0277

OCF/Sales

-4.3461

FCF/OCF

1.0003

CF Coverage

-0.6580

ST Coverage

-2.8550

CapEx Coverage

-2921.4404

Div&CapEx Cov

-2921.4404

P/BV

0.6194

P/B

0.6194

P/S

2.7124

P/E

-0.2508

P/FCF

-0.6239

P/OCF

-0.6772

P/CF

-0.6772

PEG

0.0148

P/S

2.7124

EV Multiple

-2.5706

P/FV

0.6194

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 03, 20:40 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBT, NDOI, RDFN on Behalf of Shareholders Benzinga May 02, 22:30 STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - ALBT, NDOI, DNB, RSLS GlobeNewswire Inc. May 01, 23:00 $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – ALBT, NDOI, DNB, RSLS

Revenue Product Segmentation